These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 33393204)
1. Metabolic requirements of pulmonary fibrosis: role of fibroblast metabolism. Hamanaka RB; Mutlu GM FEBS J; 2021 Nov; 288(22):6331-6352. PubMed ID: 33393204 [TBL] [Abstract][Full Text] [Related]
2. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts. Cho N; Razipour SE; McCain ML Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479 [TBL] [Abstract][Full Text] [Related]
3. The Novel Small Molecule BTB Inhibits Pro-Fibrotic Fibroblast Behavior though Inhibition of RhoA Activity. Rackow AR; Nagel DJ; Zapas G; Clough RS; Sime PJ; Kottmann RM Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233248 [TBL] [Abstract][Full Text] [Related]
4. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis. Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381 [TBL] [Abstract][Full Text] [Related]
5. The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer. Hamanaka RB; Mutlu GM Amino Acids; 2021 Dec; 53(12):1851-1862. PubMed ID: 33963932 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype. Epstein Shochet G; Wollin L; Shitrit D Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550 [TBL] [Abstract][Full Text] [Related]
7. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways. Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003 [TBL] [Abstract][Full Text] [Related]
8. FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro. Joannes A; Brayer S; Besnard V; Marchal-Sommé J; Jaillet M; Mordant P; Mal H; Borie R; Crestani B; Mailleux AA Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L615-29. PubMed ID: 26773067 [TBL] [Abstract][Full Text] [Related]
9. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways. Tumelty KE; Smith BD; Nugent MA; Layne MD J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132 [TBL] [Abstract][Full Text] [Related]
10. Hsp90 regulation of fibroblast activation in pulmonary fibrosis. Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659 [TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo. Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191 [TBL] [Abstract][Full Text] [Related]
13. Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression. Yang DC; Li JM; Xu J; Oldham J; Phan SH; Last JA; Wu R; Chen CH FASEB J; 2019 Dec; 33(12):14354-14369. PubMed ID: 31661644 [TBL] [Abstract][Full Text] [Related]
14. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production. Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709 [TBL] [Abstract][Full Text] [Related]
15. Defining the Activated Fibroblast Population in Lung Fibrosis Using Single-Cell Sequencing. Peyser R; MacDonnell S; Gao Y; Cheng L; Kim Y; Kaplan T; Ruan Q; Wei Y; Ni M; Adler C; Zhang W; Devalaraja-Narashimha K; Grindley J; Halasz G; Morton L Am J Respir Cell Mol Biol; 2019 Jul; 61(1):74-85. PubMed ID: 30848683 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis. Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446 [TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Inoue Y; King TE; Barker E; Daniloff E; Newman LS Am J Respir Crit Care Med; 2002 Sep; 166(5):765-73. PubMed ID: 12204879 [TBL] [Abstract][Full Text] [Related]
18. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy. Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568 [TBL] [Abstract][Full Text] [Related]
19. Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis. Mei Q; Liu Z; Zuo H; Yang Z; Qu J Front Pharmacol; 2021; 12():797292. PubMed ID: 35126134 [TBL] [Abstract][Full Text] [Related]
20. Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis. Gajjala PR; Kasam RK; Soundararajan D; Sinner D; Huang SK; Jegga AG; Madala SK JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34520400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]